Interestingly, for the hypervariable+hypermethylated DVMC class, we observed a significant association with HER2 status, indicating that breast cancers which exhibit stronger progressive DNAm deviations from their normal-adjacent tissue are more likely to be HER2+ breast cancers (Fig. 6e and Supplementary Table 9). The gene discussed is ERBB2; the disease is breast cancer.